Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ancrod (Viprinexun) (2 trials)
corticorelin ovine triflutate (acthrel) (3 trials)
Brain Edema (Phase 3)
Brain Infarction (Phase 3)
Brain Ischemia (Phase 3)
Brain Neoplasms (Phase 3)
Cerebral Infarction (Phase 3)
Edema (Phase 3)
Infarction (Phase 3)
Ischemia (Phase 3)
Stroke (Phase 3)
Trials (5 total)
Trial APIs (2 total)